Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy J. Cobo, L. Garcia San Miguel, G. Euba,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

N. Benito, M. Franco, A. Ribera, A. Soriano, D. Rodriguez-Pardo, L

L. Boyanova Clinical Microbiology and Infection

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study D. Rodríguez-Pardo,

KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics E. Tornero, L. Morata,

P. Melin Clinical Microbiology and Infection

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos,

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

Postoperative urinary tract infection and surgical site infection in instrumented spinal surgery: is there a link? S. Núñez-Pereira, D. Rodríguez-Pardo,

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Assessing the residual antibacterial activity of clinical materials disinfected with glutaraldehyde, o-phthalaldehyde, hydrogen peroxide or 2-bromo-2-nitro-1,3-

R. Cantón Clinical Microbiology and Infection

Public health significance of invasive mosquitoes in Europe

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

F.R. Gómez, E.P. de la Llave, J.M. García-Lechuz Moya

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study D. Rodríguez-Pardo,

Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy J. Cobo, L. Garcia San Miguel, G. Euba,

Elements of design: the knowledge on which we build

The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.

Levofloxacin in the treatment of ventilator-associated pneumonia

Metagenomics and probiotics

B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas

Hepatitis B and C virus-related carcinogenesis

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

Recent developments in staphylococcal scalded skin syndrome

The practice of travel medicine in Europe

Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study V.

Systematic review of antibiotic consumption in acute care hospitals

M. -J. Rodríguez-Hernández, M. E. Jiménez-Mejias, C. Pichardo, L

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience G.L. Pavoni, M. Giannella, M. Falcone, L.

Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.

Clinical infection services—the Leiden experience

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

W. Eugene Sanders, Christine C. Sanders

J.M. García-Lechuz, M. Sánchez-Conde, L. Muñoz, C. Benito

First isolation of Conidiobolus sp

M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Carratalà J. Clinical Microbiology and Infection

Are we losing the fight against malaria one more time?

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy J. Cobo, L. Garcia San Miguel, G. Euba, D. Rodríguez, J.M. García-Lechuz, M. Riera, L. Falgueras, J. Palomino, N. Benito, M.D. del Toro, C. Pigrau, J. Ariza Clinical Microbiology and Infection Volume 17, Issue 11, Pages 1632-1637 (November 2011) DOI: 10.1111/j.1469-0691.2010.03333.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Description of outcomes of early PJI treated with conservative strategy (see text for definition of groups A, B and C). Clinical Microbiology and Infection 2011 17, 1632-1637DOI: (10.1111/j.1469-0691.2010.03333.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions